Inventaire - your friends and communities are your best library

Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study

author

José Labarere

1971 -

published in: Haematologica

date of publication: 2019-04-19

main subject: flow cytometry

Cites articles 36

Date

Title

Authors

2018-12-07

Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow Cytometry

Claude Lambert
2017-01-01

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Guillermo Garcia-Manero, Hans Joachim Deeg
2017-07-05

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.

Torsten Haferlach, Ulrich Germing, Aristoteles A N Giagounidis, Alberto Orfao, Reinhard Stauder
2016-01-01

Myelodysplastic syndromes: Contemporary review and how we treat

Ayalew Tefferi
2016-01-20

Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase

A Richard Kitching
2016-05-19

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Clara D. Bloomfield, James W Vardiman, Michelle M Le Beau
2016-08-17

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Hagop Kantarjian, Pierre Fenaux, Guillermo Garcia-Manero, Ulrich Germing, Michelle M Le Beau, Guillermo F Sanz, Mikkael A Sekeres, Jaroslaw P. Maciejewski, Heinz Tuechler, Julie Schanz, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Marilyn L Slovak, Yasushi Miyazaki, Michael Pfeilstöcker, Wolfgang R Sperr, Reinhard Stauder, Sudhir Tauro, Teresa Vallespi, Everett Peter Greenberg
2014-06-12

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Sergio Matarraz, Peter Valent, Alberto Orfao
2014-07-25

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Valeria Santini, ESMO Guidelines Working Group, Pierre Fenaux
2013-08-26

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Eva Hellström-Lindberg, Pierre Fenaux, Ulrich Germing, Norbert Gattermann, Uwe Platzbecker, Reinhard Stauder, Arjan A van de Loosdrecht
2013-09-01

Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteria

Dragan Jevremovic
2013-09-01

Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical method.
2013-10-21

Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study
2012-03-13

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes

Norbert Gattermann
2012-03-25

Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias

Xiangdong Xu
2012-05-23

Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia

Guillermo Garcia-Manero
2012-12-06

Strategies of pain reduction during the bone marrow biopsy

Kazimierz Halaburda, Emilian Snarski
2011-02-02

Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies.

Giuliana Alimena
2011-03-23

Using a powered bone marrow biopsy system results in shorter procedures, causes less residual pain to adult patients, and yields larger specimens
2011-08-02

Verification problems in diagnostic accuracy studies: consequences and solutions

Nandini Dendukuri, Patrick Bossuyt, Johannes B Reitsma
2011-09-13

Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
2011-10-18

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Penny F Whiting, Patrick Bossuyt, Jonathan Deeks, Johannes B Reitsma, Mariska Leeflang, Jonathan Sterne
2009-03-17

Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows
2009-03-01

Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes

Michalis Michael
2009-11-05

Myelodysplastic Syndromes

Ayalew Tefferi, James W Vardiman
2008-11-01

Bone marrow biopsies in patients 85 years or older
2006-09-01

Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004
2005-03-01

Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

Selina Luger, Jo-Anne Vergilio
2005-07-01

Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes

Selina Luger, Jo-Anne Vergilio
2004-07-24

Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution

Matthias Egger
2002-03-01

The architecture of diagnostic research
1999-06-01

Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes

Article - wd:Q90024693

Welcome to Inventaire

the library of your friends and communities

learn more